Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature.

Liu, Kai; Bao, Jian-Feng; Wang, Tao; Yang, Hao; Xu, Bao-Ping

Liu, Kai; Bao, Jian-Feng; Wang, Tao; Yang, Hao; Xu, Bao-Ping.

Afiliação

Liu K; Department of Radiotherapy, Traditional Chinese Hospital of Lu'an affiliated to Anhui University of Traditional Chinese Medicine, Lu'an 237000, Anhui Province, China.
Bao JF; Department of Immunology, Xixi Hospital of Hangzhou affiliated to Zhejiang University of Traditional Chinese Medicine, Hangzhou 310023, Zhejiang Province, China.
Wang T; Department of Urology, Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine, Zhongshan 528401, Guangdong Province, China.
Yang H; Department of Critical Care Medicine, Traditional Chinese Hospital of Lu'an affiliated to Anhui University of Traditional Chinese Medicine, Lu'an 237000, Anhui Province, China.
Xu BP; Department of Critical Care Medicine, Traditional Chinese Hospital of Lu'an affiliated to Anhui University of Traditional Chinese Medicine, Lu'an 237000, Anhui Province, China. xu131406@qq.com.

World J Clin Cases ; 10(18): 6198-6204, 2022 Jun 26.

Article em En | MEDLINE | ID: mdl-35949858

Palavras-chave

Anaphylactic shock; Anti-programmed cell death one antibodies; Camrelizumab; Case report; Immunotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Clin Cases Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google